DUMC Ped. CRS

Durham, North Carolina 277103499

0 studies enrolling now · 32 studies all time

What they study most

Dyslipidemia, H1N1 Influenza Virus, HIV Infections, HIV Lipodystrophy Syndrome, HIV Seronegativity, HIV-Associated Lipodystrophy Syndrome, Influenza, Lipodystrophy, Measles, Meningitis, Osteopenia, Osteoporosis

Studies at this site

• Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After Pregnancy — Completed
• Blood Levels of Anti-HIV Drugs Used in Combination Regimens in HIV Infected Children — Completed
• Atazanavir Used in Combination With Other Anti-HIV Drugs in HIV-Infected Infants, Children, and Adolescents — Completed
• Safety of and Immune Response to a Novel Human Papillomavirus Vaccine in HIV Infected Children — Completed
• Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women — Completed
• Safety of and Immune Response to an H1N1 Influenza Virus Vaccine in HIV Infected Children and Youth — Completed
• Safety and Effectiveness of Emtricitabine, Efavirenz, and Didanosine in HIV Infected Children Who Have Taken Few or No Anti-HIV Drugs — Completed
• A Randomized, Comparative Trial of Zidovudine (AZT) Versus 2',3'-Didehydro-3'-Deoxythymidine (Stavudine; d4T) in Children With HIV Infection — Completed
• A Study of Dideoxycytidine Plus Zidovudine (AZT) in HIV-Infected Children Who Have Taken AZT — Completed
• Comparison of Stavudine Used Alone or in Combination With Didanosine in HIV-Infected Children — Completed
• Comparison of Two Dosage Regimens of Oral Dapsone for Prophylaxis of Pneumocystis Carinii Pneumonia in Pediatric HIV Infection — Completed
• A Phase I Study to Evaluate the Safety and Immunogenicity of Recombinant HIV-1 Envelope Antigen in Children Born to HIV-Infected Mothers — Completed
• Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth — Completed
• A Placebo-Controlled, Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of Recombinant Envelope Proteins of HIV-1 gp160 and gp120 in Children >= 1 Month Old With Asymptomatic HIV Infection — Completed
• Safety and Pharmacokinetics (PK) of Raltegravir in HIV (Human Immunodeficiency Virus)-Infected Children and Adolescents — Completed
• Growth Hormone Treatment of Children With HIV-Associated Growth Failure — Completed
• Combination Treatment With and Without Protease Inhibitors for Women Who Begin Therapy for HIV Infection During Pregnancy — Completed
• Safety of Saquinavir and High Doses of Lopinavir/Ritonavir in Children With HIV — Completed
• Safety of and Immune Response to Two Influenza Vaccines in HIV Infected Children and Adolescents — Completed
• A Comparison of Two Anti-HIV Drug Regimens for Youth Who Have Failed Prior Therapy — Completed
• Safety of Recombinant HIV Vaccines in HIV Infected Young Adults on Stable Therapy — Completed
• A Study of Dideoxyinosine (ddI) in HIV-Infected Children Who Have Not Had Success With Zidovudine or Who Cannot Take Zidovudine — Completed
• A Phase I Trial to Evaluate Didanosine (ddI) in HIV-Infected Pregnant Women — Completed
• Phase I Safety and Pharmacokinetics Study of Microparticulate Atovaquone (m-Atovaquone; 566C80) in HIV-Infected and Perinatally Exposed Infants and Children — Completed
• The Safety and Effects of 1592U89 Used Alone or in Combination With Other Anti-HIV Drugs in HIV-Infected Infants and Children — Completed
• A Study to Test the Safety, Tolerance, and Metabolism of Abacavir (1592U89, ABC) With Standard Zidovudine (ZDV) Therapy in Newborn Infants Born to HIV-1 Infected Women — Completed
• A Phase II, Comparative Study of Seroconversion of Single-Dose and Two-Dose Measles Vaccination in HIV-Infected and HIV-Uninfected Children: A Multicenter Trial of the Pediatric AIDS Clinical Trials Group — Completed
• A Double-Blind Placebo-Controlled Trial of the Safety and Immunogenicity of a Seven Valent Pneumococcal Conjugate Vaccine in Presumed HIV-Infected Infants — Completed
• A Trial of Two Doses of 2',3'-Dideoxycytidine (ddC) in the Treatment of Children With Symptomatic HIV Infection Who Are Intolerant of AZT and/or Who Show Progressive Disease While on AZT — Completed
• Evaluating the Safety and Immunogenicity of a Human Parainfluenza Type 3 (HPIV3) Virus Vaccine in Infants and Children — Completed
• A Study of Physical and Metabolic Abnormalities in HIV Infected and Uninfected Children and Youth — Completed
• Factors Affecting Adherence to Anti-HIV Drug Regimens in Children and Adolescents — Completed